Director, Federal Government Affairs (Democratic Lead)

A minimum of 10 years of relevant experience in federal government affairs, congressional work, biopharma policy advocacy, or life-sciences government relations

A bachelor’s degree is required, advanced degree in public policy, law, political science, or a related field preferred

Strong preference for candidates who have operated at the senior-most levels of Democratic House offices (e.g., Chief of Staff, Legislative Director, senior committee counsel/advisor), demonstrating trusted relationships and deep understanding of congressional decision-making dynamics

Established relationships within the U.S. Congress, federal agencies, and the White House, with a demonstrated track record of successful engagement and influence

Strong knowledge of health policy, drug development processes, regulatory frameworks, and issues central to the biopharmaceutical ecosystem

Familiarity with issues related to FDA policy, clinical development, incentives for innovation, and access for rare disease therapies is highly desirable

Reporting to the Executive Director, Government Affairs, the Director will help drive BridgeBio’s federal policy strategy and shape the company’s engagement across Congress, federal agencies, and key industry coalitions. You will serve as a principal representative and strategic lead of BridgeBio’s federal policy strategy, ensuring the company’s voice is clearly represented in the national debates shaping drug development, biomedical innovation, and patient access to life-changing therapies.

This role is a core member of BridgeBio’s Policy & Advocacy team, a highly collaborative function that works across scientific, regulatory, commercial, patient advocacy, and communications units to anticipate policy risks and shape opportunities that impact BridgeBio’s pipeline and patient communities. The Director will be responsible for building and sustaining trusted relationships with lawmakers, committee staff, and aligned stakeholders, ensuring BridgeBio is positioned as a credible and influential stakeholder.

The Director will anticipate and interpret legislative and policy developments, translating federal policy shifts into strategic guidance that informs enterprise planning and pipeline strategy. They will advise senior leadership and inform enterprise decision-making to support senior executives, program leaders, and affiliate organizations as they engage in matters affecting drug development, rare disease therapies, oncology innovation, and market access. The Director will help shape the company’s federal political engagement strategy, ensuring alignment with BridgeBio’s long-term scientific and policy objectives.

The Director will embody BridgeBio’s science-driven, entrepreneurial culture in advancing its federal policy priorities.

The ideal candidate is an experienced, strategic legislative or government affairs professional with a deep understanding of the federal policy environment shaping drug development, biomedical innovation, and patient access. This individual brings a proven track record of building trusted, influential relationships across Congress, federal agencies, and the broader health policy ecosystem. They are energized by complex, evolving policy challenges and know how to translate those challenges into actionable strategies that advance organizational priorities.

We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.

Financial Benefits:

Market leading compensation

401K with 100% employer match on first 3% & 50% on the next 2%

Employee stock purchase program

Pre-tax commuter benefits